A number of Class A Hospitals in China
In August 2018, Jiuzhitang Maker and Beijing Tiantan Hospital signed the “Co-establishment Agreement for Stem Cell Clinical Research Base”. Both parties will continue to advance the preclinical research work on stem cells, and Tiantan Hospital experts will act as the main principal investigator of the clinical trials "Stem cell treatment of stroke sequelae" and "Stem cell treatment of Alzheimer's disease". At present, the research base jointly built by both parties has been completed. In the future, more research will be carried out on the efficacy of stem cell drugs, and the application of other indications will be further developed.
The 2nd Affiliated Hospital of Harbin Medical University
With the lot area being 500,000 m2 and floor area being 530,000 m2, the 2nd Affiliated Hospital of Harbin Medical University has 1 outpatient department, 11 inpatient departments and 4 specialized hospitals dedicated to treatment of rheumatism, cardiovascular disorders, diseases involving the five sense organs and diabetes.
In May 2020, by signing a Cooperation Agreement, Jiuzhitang Maker and the 2nd Affiliated Hospital of Harbin Medical University agreed to jointly apply for a filed clinical study on stem cells with National Health Commission.